companydata.dkcompanydata.dk

MedTravest II ApS: Financial statements 2025

CVR: 42368032

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

MedTravest II ApS (CVR 42368032) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -186,772 and a net result of DKK -186,772 compared with DKK -23,546 the year before. Equity in the 2025 report amounted to DKK 7,565,001. The solvency ratio was 96.2%.

Gross Profit
DKK -186,772
Profit/Loss
DKK -186,772
Equity
DKK 7,565,001
Total Assets
DKK 7,862,203
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--187K-187K7.6M0
2024--19K-24K7.6M-
2023--19K-19K7.7M-
2022---38K7.7M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is MedTravest II ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Jens Strathe joins the board of MedTravest II ApSOct 30, 2025

As of October 30, 2025, Jens Strathe has joined the board of directors of MedTravest II ApS.

Peter Juul Kristensen leaves the board of MedTravest II ApSOct 30, 2025

As of October 30, 2025, Peter Juul Kristensen has left the board of directors of MedTravest II ApS.

Jens Strathe joins MedTravest II ApS as directorOct 30, 2025

As of October 30, 2025, Jens Strathe is registered as director of MedTravest II ApS.

Peter Juul Kristensen steps down as director of MedTravest II ApSOct 30, 2025

As of October 30, 2025, Peter Juul Kristensen has stepped down as director of MedTravest II ApS.

MedTravest II ApS: The 2024 annual report is outJun 26, 2025

MedTravest II ApS has published its annual report for 2024. Gross profit came to DKK -19,000, and the net result was DKK -23,546.

About MedTravest II ApS

MedTravest II ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named ApS STAKE nr. 6158. The management consists of Jens Strathe. The board consists of Mark Lund Andersen (chair), Jens Strathe and Tore Jesper Andersen. The company's owners include STRATHE INVEST ApS, JUUL KRISTENSEN HOLDING ApS and MedTravest A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -186,772 and a net result of DKK -186,772 compared with DKK -23,546 the year before. Equity in the 2025 report amounted to DKK 7,565,001.

Source: annual report 2025, Danish Business Authority

Other financial years